Skip to main content
. 2022 Aug 15;30(2):135–143. doi: 10.1097/LBR.0000000000000889

TABLE 2.

Tumor Response After PDT Light Applications

Patient # Diagnosis Tumor Size (cm) PDT Light Applications (Day 3) Tumor Response Days From PDT to Surgery Tumor Cell Necrosis (%) Brisk Inflammatory Reaction
Nonresection study
1 Squamous cell carcinoma 2.8 1 3 mo: SD 6 mo: PD
2 Carcinoid 1.6 1 3 mo: SD 6 mo: SD
3 Adenocarcinoma metastasis from colon 1.5 3 3 mo: SD 6 mo: SD
4 Squamous cell carcinoma 1.1 2, 2*;2*, 1* 3 mo: CR 6 mo: CR
5 Adenocarcinoma 1.3 1 3 mo: SD 6 mo: SD
Resection study
1 Adenocarcinoma 3.00 1 No 12 20 Yes
2 Squamous cell 1.30 1 No 13 40 Yes
3 Adenocarcinoma 2.60 1 No 14 40 Yes
4 Adenocarcinoma 2.77 3 No 15 35 Yes
5 Squamous cell 1.80 1 Yes 32 No residual tumor Not applicable
6 Adenocarcinoma 3.30 2 No 15 10 Yes
7 Adenocarcinoma 2.10 3 No 12 5 Yes
8 Adenocarcinoma 1.70 2 No 12 10 Yes
9 Adenocarcinoma 2.10 1 No 13 50 Yes
10 Adenocarcinoma 2.10 4 No 18 10 Yes
*

PDT applications after first porfimer sodium injection: 2 on day 3, 2 on day 5; after second porfimer sodium injection: 2 on day 3, 2 on day 6.

No nonviable/necrotic tumor at resection.

4 placements for total dose of 200 J.

—indicates not evaluated, no tumor resection in this study; PDT, photodynamic therapy.